Gamucci Alessandra, Uccella Sara, Sciarretta Lucia, D'Apruzzo Maria, Calevo Maria Grazia, Mancardi Maria Margherita, Veneselli Edvige, De Grandis Elisa
1 Child Neuropsychiatry Unit, Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics and Maternal and Children's Sciences, Istituto Giannina Gaslini, University of Genoa, Genoa, Italy.
2 Epidemiology, Biostatistics and Committees Unit, Istituto Giannina Gaslini, Genoa, Italy.
J Child Adolesc Psychopharmacol. 2019 May;29(4):305-312. doi: 10.1089/cap.2018.0087. Epub 2019 Feb 6.
Whether PANS (pediatric acute-onset neuropsychiatric syndrome) and PANDAS (pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection) represent true clinical entities is debated and data for a characteristic phenotype are still controversial. In this study, we aim to characterize clinical, neuropsychological, and biochemical aspects in a sample of PANS and PANDAS patients. Patients fulfilling a clinical diagnosis of PANS or PANDAS from 2014 to 2017 were enrolled. Neurological and psychiatric examination and biochemical and instrumental assessment results were collected. A neuropsychological battery was administered. For comparison purposes, a control group of patients with Sydenham's chorea (SC) was evaluated. Descriptive and comparative statistical analyses were performed. Seven subjects received a diagnosis of PANS, 12 of PANDAS, and 11 of SC. Clinical presentation of PANS children showed statistically significant differences compared with both PANDAS and SC, in particular, with the presence of obsessive symptoms, behavioral regression, and somatic symptoms in the first group. Moreover, all PANS patients showed some neuropsychological deficits in visual-motor abilities, short- and long-term memory, and processing speed. Our experience confirms that patients with PANS had a complex clinical presentation and a compromised neuropsychological profile with respect to patients with PANDAS or SC. However, the absence of biological markers or instrumental alterations made the diagnosis of the two entities, PANS and PANDAS, a matter of exclusion. For these reasons, we propose a pilot diagnostic protocol that (when applied in a prospective manner) will allow comparison with similar childhood-onset neuropsychiatric disorders, such as obsessive-compulsive or tic disorders, and efficacy evaluation of different therapeutic approaches.
小儿急性起病神经精神综合征(PANS)和小儿自身免疫性神经精神障碍伴链球菌感染(PANDAS)是否代表真正的临床实体仍存在争议,关于其特征性表型的数据也仍有争议。在本研究中,我们旨在对一组PANS和PANDAS患者的临床、神经心理学和生化方面进行特征描述。纳入了2014年至2017年临床诊断为PANS或PANDAS的患者。收集了神经和精神检查结果以及生化和器械评估结果。进行了一套神经心理测试。为作比较,对一组患有 Sydenham舞蹈病(SC)的患者进行了评估。进行了描述性和比较性统计分析。7名受试者被诊断为PANS,12名被诊断为PANDAS,11名被诊断为SC。PANS患儿与PANDAS和SC患儿相比,临床表现存在统计学上的显著差异,特别是第一组中存在强迫症状、行为倒退和躯体症状。此外,所有PANS患者在视运动能力、短期和长期记忆以及处理速度方面均表现出一些神经心理缺陷。我们的经验证实,与PANDAS或SC患者相比,PANS患者的临床表现复杂,神经心理状况受损。然而,缺乏生物标志物或器械改变使得PANS和PANDAS这两种实体的诊断只能通过排除法进行。基于这些原因,我们提出了一个初步诊断方案,该方案(以前瞻性方式应用时)将允许与类似的儿童期起病神经精神障碍(如强迫症或抽动障碍)进行比较,并对不同治疗方法进行疗效评估。